Retinitis Pigmentosa Market Patient-Centered Care Models and Strategies

Introduction

• Research Objective
• Scope of the Study
• Definition and Taxonomy

Research Methodology

• Research Approach
• Data Sources
• Assumptions

Executive Summary

• Synopsis
• Analyst Recommendations

Market Overview 

• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Value Chain Analysis
  • Raw Material Sourcing
  • Manufacturing Process
  • Logistics & Transportation
  • Buyer Preferences
• Trends
  • Market Trends
  • Technological Trends
• Porter’s Five Forces Analysis
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of Substitute
  • Threat of New Entrants
  • Degree of Competition
• PESTLE Analysis for 5 Leading Countries
  
  • Regulatory Framework for Leading Countries/Regions
  • Supply Demand Analysis
  • Production & Consumption Statistics
  • Export Import Statistics
  • Price Trend Analysis

Global Retinitis Pigmentosa Market Assessment

• Overview
• Global Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
  • Autosomal Dominant RP
  • Autosomal Recessive RP
  • X-linked RP
• Global Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
  • Vit A Supplements
  • Gene Therapy
  • Vit A Supplements
  • Gene Therapy
  • Retinal Implants
  • Low Vision Aids
  • Surgery
  • Others
• Global Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

North America Retinitis Pigmentosa Market Assessment

• Overview
• North America  Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
  • Autosomal Dominant RP
  • Autosomal Recessive RP
  • X-linked RP
• North America Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
  • Vit A Supplements
  • Gene Therapy
  • Vit A Supplements
  • Gene Therapy
  • Retinal Implants
  • Low Vision Aids
  • Surgery
  • Others

Europe Retinitis Pigmentosa Market Assessment

• Overview
• Europe Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
  • Autosomal Dominant RP
  • Autosomal Recessive RP
  • X-linked RP
• Europe Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
  • Vit A Supplements
  • Gene Therapy
  • Vit A Supplements
  • Gene Therapy
  • Retinal Implants
  • Low Vision Aids
  • Surgery
  • Others

Asia Pacific Retinitis Pigmentosa Market Assessment

• Overview
• Asia Pacific Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
  • Autosomal Dominant RP
  • Autosomal Recessive RP
  • X-linked RP
• Asia Pacific Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
  • Vit A Supplements
  • Gene Therapy
  • Vit A Supplements
  • Gene Therapy
  • Retinal Implants
  • Low Vision Aids
  • Surgery
  • Others

Latin America Retinitis Pigmentosa Market Assessment

• Overview
• Latin America Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
  • Autosomal Dominant RP
  • Autosomal Recessive RP
  • X-linked RP
• Latin America Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
  • Vit A Supplements
  • Gene Therapy
  • Vit A Supplements
  • Gene Therapy
  • Retinal Implants
  • Low Vision Aids
  • Surgery
  • Others

Middle East and Africa Retinitis Pigmentosa Market Assessment

• Overview
• Middle East and Africa Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Disease Type (2021 – 2033)
  • Autosomal Dominant RP
  • Autosomal Recessive RP
  • X-linked RP
• Middle East and Africa Retinitis Pigmentosa Market Size Value (US$) and Volume (Billion Tons), by Treatment Type (2021 – 2033)
  • Vit A Supplements
  • Gene Therapy
  • Vit A Supplements
  • Gene Therapy
  • Retinal Implants
  • Low Vision Aids
  • Surgery
  • Others

Company Profiles

• Novartis
  • Company Overview
  • Geographic Footprints
  • Financial Performance
  • Product Portfolio
  • SWOT Analysis
  • R&D Efforts
  • Recent Developments & Strategic Collaborations
    • Product Launch/M&A/Technical Collaboration
• Roche (Spark Therapeutics Inc)
• MeiraDx
• Astellas Pharma Inc.
• Clino Corporation
• Gensight Biologics
• InFlectis BioScience
• Bausch Health Companies Inc.
• Adverum Biotechnologies
• ReGenx Biosciences

Conclusion & Recommendations